News | Catheters | May 10, 2022

WLNC Highlights Q Catheter Compatibility in Simulated Robotic Thrombectomy

The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end. This feature has demonstrated in simulated use studies that the Q Catheter may be uniquely suited to allow physicians in the future to treat ischemic stroke patients remotely via a robot from a different room, a different city, or even a different country. 

May 10, 2022 — The MIVI Neuroscience Q Aspiration Catheter incorporates a novel pusher wire design on its proximal end. This feature has demonstrated in simulated use studies that the Q Catheter may be uniquely suited to allow physicians in the future to treat ischemic stroke patients remotely via a robot from a different room, a different city, or even a different country. 

Dr. Demetrius Lopes of Advocate Lutheran General Hospital in Park Ridge, Illinois, has conducted flow-model compatibility testing with the Q catheter and the Corindus GRX robot. Using a simulated neurovascular model, Lopes has been able to show preliminary compatibility between the Q Catheter and the robot system and perform a successful thrombectomy procedure. Lopes will present his experience at the World Live Neurovascular Conference (WLNC) May 11-13 in Washington, D.C.

The Corindus GRX Vascular Robotic system is currently approved for use in endovascular coronary and peripheral therapies, and FDA approval for a neurovascular indication may be on the horizon. The robotic system is designed to be used with rapid exchange angioplasty balloons and balloon-mounted stents, which is the preferred platform in cardiology.

Due to its unique design, the Q Catheter functions with the robot very similarly to these rapid exchange devices. The Q Catheter, currently FDA cleared for use with compatible guide catheters in facilitating the insertion and guidance of microcatheters into a selected blood vessel in the peripheral, coronary and neuro vascular systems, is not currently cleared for thrombectomy but is currently in a clinical study for future market clearance in the U.S.

“Not only does the Q Catheter’s design maximize aspiration force for the best chance at revascularization, it also overcomes the challenge of the robotic system and limitations of traditional catheters” said Lopes. “I was very pleased with the Q Catheter tracking and aspiration performance in this initial testing with the robot.”     

Bob Colloton, CEO of MIVI Neuroscience, commented “As a company, our goal is to meet the unmet needs of our neurovascular physicians with innovative solutions. Regardless of where or how the procedure is performed, we want physicians to be able to choose the Q Catheter because it offers the highest aspiration power and a simple, single-operator setup. We are proud to partner with Dr. Lopes to show that the Q Catheter is well-poised for the future of mechanical thrombectomy.”

Q Catheter for Neurovascular Thrombectomy: CAUTION­­ Investigational device. Limited by United States law to investigational use.

For more information: www.mivineuro.com

Related Robots in the Cath Lab Content:

VIDEO: Robotic PCI Performed Well in Real-World Population in the PRECISION GRX Study — Ehtisham Mahmud, M.D.

Second Generation Robotic PCI System Performs Well Across Spectrum of Lesion Complexity

VIDEO: Standardizing PCI Through Smart Robotic Procedural Automation

Corindus Launches technIQ 1 Smart Procedural Automation Series for CorPath GRX Cath lab Robotic System

FDA Clears Corindus CorPath GRX for Peripheral Vascular Interventions

VIDEO: Corindus CorPath Robotic PCI System For The Cardiac Cath Lab

Corindus CorPath Used in World's First-in-Human Telerobotic Coronary Intervention

14 Ways to Reduce Radiation Exposure in the Cath Lab

Corindus Seeking Neurovascular Intervention Clearance for CorPath GRX Vascular Robotic System

Innovations Driving the Cath Lab Technology of Tomorrow

Siemens Completes Acquisition of Cath Lab Robotics Vendor Corindus

First Robotic Coronary Angioplasties Performed With Robocath System in Germany

Hoag Performs First Robotic Carotid Artery Stenting on West Coast


Related Content

News | Catheters

July 1, 2025 — Stereotaxis, a provider of surgical robotics for minimally invasive endovascular intervention, has ...

Home July 10, 2025
Home
News | Catheters

May 21, 2025 – Johnson & Johnson MedTech has announced the U.S. launch of the Soundstar Crystal Ultrasound Catheter for ...

Home May 22, 2025
Home
News | Catheters

December 5, 2022 — The U.S. Food and Drug Administration (FDA) is alerting health care facilities and providers of a ...

Home December 05, 2022
Home
Feature | Catheters | By Allied Market Research

According to a new report from Allied Market Research, the global catheters market was valued at $22.7 billion in 2021 ...

Home June 09, 2022
Home
News | Catheters
April 21, 2022 – MIVI Neuroscience, Inc., innovator of the next generation of neurointerventional medical devices, today ...
Home April 21, 2022
Home
News | Catheters

February 9, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, has announced that the company has ...

Home February 09, 2022
Home
News | Catheters

October 23, 2019 — BioCardia announced the U.S. commercial availability of its Avance Bi-Directional Steerable ...

Home October 23, 2019
Home
Technology | Catheters

August 23, 2019 — Cook Medical recently released the second generation of the 2.6 Fr CXI Support Catheter with platinum ...

Home August 23, 2019
Home
Technology | Catheters

May 16, 2019 — BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable ...

Home May 16, 2019
Home
Subscribe Now